{"name":"Advanced Dermatology","slug":"advanced-dermatology","ticker":"","exchange":"","domain":"","description":"Advanced Dermatology is a specialty pharmaceutical company focused on developing and marketing innovative dermatological products. The company has a portfolio of six marketed products, including Null Formula 8-in-1 BioSerum, Null Formula 2-Minute Reveal Masque, and Null Formula 24/7 Barrier Repair Cream.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Null Formula 8-in-1 BioSerum","genericName":"Null Formula 8-in-1 BioSerum","slug":"null-formula-8-in-1-bioserum","indication":"Other","status":"marketed"},{"name":"Null Formula 2-Minute Reveal Masque","genericName":"Null Formula 2-Minute Reveal Masque","slug":"null-formula-2-minute-reveal-masque","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Null Formula 8-in-1 BioSerum","genericName":"Null Formula 8-in-1 BioSerum","slug":"null-formula-8-in-1-bioserum","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Null Formula 2-Minute Reveal Masque","genericName":"Null Formula 2-Minute Reveal Masque","slug":"null-formula-2-minute-reveal-masque","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNWDVyR1BJYlA0NWViUjFXR1pRV2IxTHNDQlNmMF9HZVFfQ3E3VnZjaDNQd1NyZ3VzdzVPellHOFpvdVBadTZNc1l3cjduV3JuVzA4M0lMcTBIeVhET0JfYlVrNUgyelNjbjNEem1iQ2wwYV9lRDdTcHJHZUFDTjNWNThDQzRtY0ZkbmJmM3d1UEtQN0NTWWNSaEtwZzQ1ZXlCdEZWN0dITQ?oc=5","date":"2026-03-20","type":"pipeline","source":"The Pharma Letter","summary":"Azitra raises up to $31.4m to expand into cosmetic dermatology - The Pharma Letter","headline":"Azitra raises up to $31.4m to expand into cosmetic dermatology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOOExPQlZ4eGdlVC1mQWxrNFBFRklYQ1JLSFhmak1LTmZSZ2tNeDBRY2h6NHFqb2tFSUJqZDNoNFJwNzk3NDk1VEJycG9xUVljN1haNVh6S1hrOUtTM2drYjBFd3ExdkgtdlUtd3VaNGJhcnpuaHc2UWlYVDVBZzFFMkppR01UVzhUQ2NFRlFWZkUtdlNic0dqTVFiczByd3dITnFfbm9vbDlhVDg4UGc?oc=5","date":"2026-03-19","type":"pipeline","source":"PMLiVE","summary":"Almirall celebrates new offices in China to advance innovation in dermatology - PMLiVE","headline":"Almirall celebrates new offices in China to advance innovation in dermatology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVVpQd2JBM1Z6VXRBbDF0R3NudndnU01mX0JUTU1CTDJjSllrNE5HVGdNMUk2MkZPVHZYNDUtaTBDMmlRUVpKZ3RPQkdGUExqd1hWUkI0a0Fma2w2Tkk1VzEtS28zMUNBUmdWX09jNlNSazNXQmd4NlZhblRJUzNCUnRTajRFTHZnYXBPamVvQ0VSNmpPaXZIOHR2UkFkVGphcmxYN2RtTnJtbmdmUHRVamxtdlNqSXhFT1J3cWxWM1Y?oc=5","date":"2026-03-12","type":"pipeline","source":"Contract Pharma","summary":"Almirall Opens New Offices in China to Advance Medical Dermatology Innovation - Contract Pharma","headline":"Almirall Opens New Offices in China to Advance Medical Dermatology Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOY3BIZUdoT3B3MkpqenY5V0RvZ0JwMExUekwtZEZBWkx1bHpoSHBIUUJsMFlyZEJ1XzdqRUU5NUJFRWlPTGhlTGdkX0V6cjIwU2J5Yk4yZExoVi14c1dKdDgwZUZ6UW4yQ1JldmtFTTJZajU0OVYzWlBMeG9HbDFuTEVGbjl3SmFYUXNKT2FVejdrVTVPcGxURHFhVU1HTXJqM25EakVzOXVuMy1GREtHbg?oc=5","date":"2026-01-16","type":"pipeline","source":"Dermatology Times","summary":"Sun Pharma’s Cosibelimab-ipdl (UNLOXCYT) Enters US Market for Advanced CSCC - Dermatology Times","headline":"Sun Pharma’s Cosibelimab-ipdl (UNLOXCYT) Enters US Market for Advanced CSCC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE02M1dtTGpDRk5KMkh5bGxzUG1ZYkRrWW5PclF6VlVHOVdoMmlTVGRPNUwyVWZOTDBpci1QYWFSWHdEdUhVMUNLVXB4QjdLME5GUnVMVF9uSGxxeGctOGVTU1lnWks0Vlc0Q0ZONGl0SWR3MDl3?oc=5","date":"2026-01-15","type":"pipeline","source":"MedPage Today","summary":"Share of Biologics Prescribed by NPs, PAs Grows Rapidly in Dermatology - MedPage Today","headline":"Share of Biologics Prescribed by NPs, PAs Grows Rapidly in Dermatology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQaUZMQjhFdWtNQ0tVV2dMUFNmRkxJeDJyNzZSOWZqR290N01VeGRBZW9ra0llVnlsVDlJWFlBSFBvUHVfOGxsSzhLQkUwTHFwWF9TZEZiZ08wY2VnOEJ5TTMyYm5lQnBwVzVSeEFMbTBsRDlrQ0xVVVVpcl9QTkx4UjZrU2ZWeVhQd293b2NaeGJnUFJJNVl0aTNRa1V0TnNYZFJHRUxzdWhlWEp5Z2MzUVk4OEs0OHd5QlZyN0VqckVYaXRJREE?oc=5","date":"2026-01-07","type":"regulatory","source":"Dermatology Times","summary":"Legacy Healthcare Receives FDA Clearance to Advance Cinainu to Phase 3 AA Clinical Trials - Dermatology Times","headline":"Legacy Healthcare Receives FDA Clearance to Advance Cinainu to Phase 3 AA Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxORUJaV3N2MjhudlBHRzhtZHpHMnpza2NRdG5kaDMwV1kyakFTOHpHamsyQXJnMjU0alphRGRMR0w5YUxXQUQ0ZTFiQ3VGaEJnV20tLUpyUHNGYkZ3eDY5aDFFUWVYT3BHUkRfSVlnSTd2dFByMm1zTnd3amRpaFJvWENsZ0RwYThUYmQ2eXk1dUVHdHZXaDNraTBZUFZUN0hlZFFraG8tOUlDQlFudkZ2Z3ZCUnh4QWJ4VzlVbTA4T0ladTRkSGtLd0lOc2dhWUtjWnlFcFp6RjJMMXlnVmc?oc=5","date":"2025-12-12","type":"pipeline","source":"PR Newswire","summary":"Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - PR Newswire","headline":"Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxONzg2cThkNExHTUs1a3N5R3cwQnVhbmU2LW9HaTY5Y1BGeXktWVdyTlhpUzk3LW9pQTF0WGVqZ0hOVzR3QlRBR05VeWdVN3VfSHpHdWZndUhOUkpMWThZMWZ2cG5GMkY2WjdyNFM5M2NheVhvM2Q1cWJzVzlpeDlrUlNWOW4yMlFMeGc?oc=5","date":"2025-09-12","type":"pipeline","source":"Dermatology Advisor","summary":"Locally Advanced Basal Cell Carcinoma: Essentials for Diagnosis and Management - Dermatology Advisor","headline":"Locally Advanced Basal Cell Carcinoma: Essentials for Diagnosis and Management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSi14MjRZNDJ0dVY5Y3Q4cUEwUVFjVHB3M1lCRldDYm5BLTREbVN3Sm9JYnpDYmZiamhqQnFfWDdaV1V3Sy1PYjNfUGJZbEZUUkt3RjlnaU81UTYxaHlvYjNNMDJWb0g5VE1vVnpCNDc5RmhvSS1Mb0xybFlFS2J2MmFvOXpoUktRU3JXLUdPeElnUjllN3FUdkF2MFQ2aU1VVFZwUDJ5UkVFQQ?oc=5","date":"2025-07-18","type":"pipeline","source":"Medscape","summary":"Volume, Not Price, Fueling Rise in Part D Specialty Derm Drug Spending - Medscape","headline":"Volume, Not Price, Fueling Rise in Part D Specialty Derm Drug Spending","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE40N0NYdVA5RnlPN0FnWW1EVE13NF9FUF9lM1k3TmloY0N4UEJkZ0lKTXBnTGUwLXVaSlRSNUcxbjZGb2hxMGVETUtEUlVKVlFndkhXU2pOU01LWmp3VVdxS2F0MkZQaGdrX0FydEhn?oc=5","date":"2025-06-23","type":"pipeline","source":"Market.us","summary":"Veterinary Dermatology Drugs Market Size Analysis | CAGR 9.7% - Market.us","headline":"Veterinary Dermatology Drugs Market Size Analysis | CAGR 9.7%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQcHBNS2JGSFdRNUN2VVRSR1VfZlNrdzFIejlQT1NOVDdjamdEQXdVWU1zRHFxMHkwWEo1d0NpclJnc3FHS2pocmNBMkN3VHIxRFl1LU1scWlHZEkxR0pnc0F4WHRFc29RdXZkQmJKaVBpdDQwZHdJQ1ppQ3plZlRjZTZkdEpMaHF4UE5zcDB0cUp5XzN2VV9wQ1ZaUlNXLTVlMWwwRFRTaHdEUTVpYVI0VHZn?oc=5","date":"2025-04-17","type":"pipeline","source":"PMLiVE","summary":"LEO Pharma and the Parker Institute join forces to advance dermatology research - PMLiVE","headline":"LEO Pharma and the Parker Institute join forces to advance dermatology research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPX1pINFRiMUtJU043ejExWDM2bEd5SDNJOENXczlvQ25TNEZiX0JteFpkeFR6MGYwMG9jOGhNNmNIZHh3Qlpzai0yclRLWWstb2hvaDJKWVNRejNNamp3UlI5NzgyMV9LcGhyNEFCd3JCVENxNFRHTzQ4QVUtVUxfMzItaUhKSTg3N0haMXktZXYwSTFOYmR5WC15TDZTRTZRVWVLLTZtSFhoTUxaNFp0X014SGJCUC1pcFBmc0I5a3IyY3M?oc=5","date":"2025-04-16","type":"pipeline","source":"Healio","summary":"Private equity in dermatology: Consolidation, modernization are on the horizon - Healio","headline":"Private equity in dermatology: Consolidation, modernization are on the horizon","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":0,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}